Low level arsenic promotes progressive inflammatory angiogenesis and liver blood vessel remodeling in mice

Toxicology and Applied Pharmacology

Volumn 222, Issue 3, 2007, Pages 327-336

  Straub, Adam C ^a   Stolz, Donna B ^b   Vin, Harina ^a,b   Ross, Mark A ^b   Soucy, Nicole V ^c   Klei, Linda R ^a   Barchowsky, Aaron ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

Arsenite; Caveolin 1; Endothelial; Macrophage; Monocyte; PECAM 1

Indexed keywords

ARSENIC; CAVEOLIN 1; CD31 ANTIGEN; CD45 ANTIGEN; CD68 ANTIGEN; DRINKING WATER; LAMININ 1; MATRIGEL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARSENIC POISONING; ARTICLE; CAVEOLA; CELL FUNCTION; CELL INFILTRATION; CONTROLLED STUDY; CORONARY BLOOD VESSEL; ENDOTHELIUM CELL; GENE EXPRESSION; INFLAMMATORY CELL; INFLAMMATORY DISEASE; INFLAMMATORY INFILTRATE; LIVER BLOOD VESSEL; LIVER TOXICITY; MALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOLOGY; PHENOTYPE; POROSITY; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD31; ARSENIC; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FLUORESCENT ANTIBODY TECHNIQUE; INFLAMMATION; LAMININ; LEUKOCYTES; LIVER CIRCULATION; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; MICROVILLI; NEOVASCULARIZATION, PATHOLOGIC; POISONS; PROTEOGLYCANS;

MUS;

EID: 34547575799     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.10.011     Document Type: Article

References (57)

1. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., and Sethi G. Inflammation and cancer: how hot is the link?. Biochem. Pharmacol. 72 (2006) 1605-1621
2. Barchowsky A., Dudek E.J., Treadwell M.D., and Wetterhahn K.E. Arsenic induces oxidant stress and NF-KappaB activation in cultured aortic endothelial cells. Free Radical Biol. Med. 21 (1996) 783-790
3. Barchowsky A., Roussel R.R., Klei L.R., James P.E., Ganju N., Smith K.R., and Dudek E.J. Low levels of arsenic trioxide stimulate proliferative signals in primary vascular cells without activating stress effector pathways. Toxicol. Appl. Pharmacol. 159 (1999) 65-75
4. Bashir S., Sharma Y., Irshad M., Nag T.C., Tiwari M., Kabra M., and Dogra T.D. Arsenic induced apoptosis in rat liver following repeated 60 days exposure. Toxicology 217 (2006) 63-70
5. Braet F. How molecular microscopy revealed new insights into the dynamics of hepatic endothelial fenestrae in the past decade. Liver Int. 24 (2004) 532-539
6. Braet F., and Wisse E. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp. Hepatol. 1 (2002) 1-17
7. Brasier A.R., Recinos III A., and Eledrisi M.S. Vascular inflammation and the renin-angiotensin system. Arterioscler., Thromb., Vasc. Biol. 22 (2002) 1257-1266
8. Bunderson M., Brooks D.M., Walker D.L., Rosenfeld M.E., Coffin J.D., and Beall H.D. Arsenic exposure exacerbates atherosclerotic plaque formation and increases nitrotyrosine and leukotriene biosynthesis. Toxicol. Appl. Pharmacol. 201 (2004) 32-39
9. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6 (2000) 389-395
10. Cogger V.C., Muller M., Fraser R., McLean A.J., Khan J., and Le Couteur D.G. The effects of oxidative stress on the liver sieve. J. Hepatol. 41 (2004) 370-376
11. Couvelard A., Scoazec J.Y., and Feldmann G. Expression of cell-cell and cell-matrix adhesion proteins by sinusoidal endothelial cells in the normal and cirrhotic human liver. Am. J. Pathol. 143 (1993) 738-752
12. Couvelard A., Scoazec J.Y., Dauge M.C., Bringuier A.F., Potet F., and Feldmann G. Structural and functional differentiation of sinusoidal endothelial cells during liver organogenesis in humans. Blood 87 (1996) 4568-4580
13. Cursiefen C., Chen L., Borges L.P., Jackson D., Cao J., Radziejewski C., D'Amore P.A., Dana M.R., Wiegand S.J., and Streilein J.W. VEGF-A stimulates lymphangiogenesis and hemangiogenesis in inflammatory neovascularization via macrophage recruitment. J. Clin. Invest. 113 (2004) 1040-1050
14. Dalgleish A.G., and O'Byrne K. Inflammation and cancer: the role of the immune response and angiogenesis. Cancer Treat. Res. 130 (2006) 1-38
15. Das S., Santra A., Lahiri S., and Guha Mazumder D.N. Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity. Toxicol. Appl. Pharmacol. 204 (2005) 18-26
16. Davis G.E., and Senger D.R. Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ. Res. 97 (2005) 1093-1107
17. DeLeve L.D., Wang X., Hu L., McCuskey M.K., and McCuskey R.S. Rat liver sinusoidal endothelial cell phenotype is maintained by paracrine and autocrine regulation. Am. J. Physiol.: Gastrointest. Liver Physiol. 287 (2004) G757-G763
18. Dubuisson L., Boussarie L., Bedin C.A., Balabaud C., and Bioulac-Sage P. Transformation of sinusoids into capillaries in a rat model of selenium-induced nodular regenerative hyperplasia: an immunolight and immunoelectron microscopic study. Hepatology 21 (1995) 805-814
19. Duyndam M.C., Hulscher S.T., van der W.E., Pinedo H.M., and Boven E. Evidence for a role of p38 kinase in hypoxia-inducible factor 1-independent induction of vascular endothelial growth factor expression by sodium arsenite. J. Biol. Chem. 278 (2003) 6885-6895
20. Engel R.R., Hopenhayn-Rich C., Receveur O., and Smith A.H. Vascular effects of chronic arsenic exposure: a review. Epidemiol. Rev. 16 (1994) 184-208
21. Esser S., Wolburg K., Wolburg H., Breier G., Kurzchalia T., and Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 140 (1998) 947-959
22. Fernandez M., Mejias M., Angermayr B., Garcia-Pagan J.C., Rodes J., and Bosch J. Inhibition of VEGF receptor-2 decreases the development of hyperdynamic splanchnic circulation and portal-systemic collateral vessels in portal hypertensive rats. J. Hepatol. 43 (2005) 98-103
23. Flora S.J., Pant S.C., Malhotra P.R., and Kannan G.M. Biochemical and histopathological changes in arsenic-intoxicated rats coexposed to ethanol. Alcohol 14 (1997) 563-568
24. Guha Mazumder D.N. Chronic arsenic toxicity: clinical features, epidemiology, and treatment: experience in West Bengal. J. Environ. Sci. Health, Part A, Toxic Hazard. Subst. Environ. Eng. 38 (2003) 141-163
25. Guyot C., Lepreux S., Combe C., Doudnikoff E., Bioulac-Sage P., Balabaud C., and Desmouliere A. Hepatic fibrosis and cirrhosis: the (myo)fibroblastic cell subpopulations involved. Int. J. Biochem. Cell Biol. 38 (2006) 135-151
26. Hayden M.R., and Tyagi S.C. Vasa vasorum in plaque angiogenesis, metabolic syndrome, type 2 diabetes mellitus, and atheroscleropathy: a malignant transformation. Cardiovasc. Diabetol. 3 (2004) 1-16
27. Hilmer S.N., Cogger V.C., Fraser R., McLean A.J., Sullivan D., and Le Couteur D.G. Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology 42 (2005) 1349-1354
28. Kamat C.D., Green D.E., Curilla S., Warnke L., Hamilton J.W., Sturup S., Clark C., and Ihnat M.A. Role of HIF signaling on tumorigenesis in response to chronic low-dose arsenic administration. Toxicol. Sci. 86 (2005) 248-257
29. Kao Y.H., Yu C.L., Chang L.W., and Yu H.S. Low concentrations of arsenic induce vascular endothelial growth factor and nitric oxide release and stimulate angiogenesis in vitro. Chem. Res. Toxicol. 16 (2003) 460-468
30. Lew Y.S., Brown S.L., Griffin R.J., Song C.W., and Kim J.H. Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown. Cancer Res. 59 (1999) 6033-6037
31. Li J., Niu J.Z., Wang J.F., Li Y., and Tao X.H. Pathological mechanisms of alcohol-induced hepatic portal hypertension in early stage fibrosis rat model. World J. Gastroenterol. 11 (2005) 6483-6488
32. Liu B., Pan S.G., Dong X.S., Qiao H.Q., Jiang H.C., Krissansen G.W., and Sun X.Y. Opposing effects of arsenic trioxide on hepatocellular carcinomas in mice. Cancer Sci. 97 (2006) 675-681
33. Mazumder D.N. Effect of chronic intake of arsenic-contaminated water on liver. Toxicol. Appl. Pharmacol. 206 (2005) 169-175
34. Moreau R. VEGF-induced angiogenesis drives collateral circulation in portal hypertension. J. Hepatol. 43 (2005) 6-8
35. Navas-Acien A., Sharrett A.R., Silbergeld E.K., Schwartz B.S., Nachman K.E., Burke T.A., and Guallar E. Arsenic exposure and cardiovascular disease: a systematic review of the epidemiologic evidence. Am. J. Epidemiol. 162 (2005) 1037-1049
36. Neubauer K., Wilfling T., Ritzel A., and Ramadori G. Platelet-endothelial cell adhesion molecule-1 gene expression in liver sinusoidal endothelial cells during liver injury and repair. J. Hepatol. 32 (2000) 921-932
37. Ng J.C., Wang J.P., Zheng B., Zhai C., Maddalena R., Liu F., and Moore M.R. Urinary porphyrins as biomarkers for arsenic exposure among susceptible populations in Guizhou province, China. Toxicol. Appl. Pharmacol. 206 (2005) 176-184
38. Penn A. International Commission for Protection Against Environmental Mutagens and Carcinogens. ICPEMC Working Paper 7/1/1. Mutational events in the etiology of arteriosclerotic plaques. Mutat. Res. 239 (1990) 149-162
39. Ricousse-Roussanne S., Barateau V., Contreres J.O., Boval B., Kraus-Berthier L., and Tobelem G. Ex vivo differentiated endothelial and smooth muscle cells from human cord blood progenitors home to the angiogenic tumor vasculature. Cardiovasc. Res. 62 (2004) 176-184
40. Roboz G.J., Dias S., Lam G., Lane W.J., Soignet S.L., Warrell Jr. R.P., and Rafii S. Arsenic trioxide induces dose- and time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood 96 (2000) 1525-1530
41. Ross M.A., Sander C.M., Kleeb T.B., Watkins S.C., and Stolz D.B. Spatiotemporal expression of angiogenesis growth factor receptors during the revascularization of regenerating rat liver. Hepatology 34 (2001) 1135-1148
42. Ruiz d.A., Luttun A., and Carmeliet P. An SDF-1 trap for myeloid cells stimulates angiogenesis. Cell 124 (2006) 18-21
43. Semela D., and Dufour J.F. Angiogenesis and hepatocellular carcinoma. J. Hepatol. 41 (2004) 864-880
44. Shigeno K., Naito K., Sahara N., Kobayashi M., Nakamura S., Fujisawa S., Shinjo K., Takeshita A., Ohno R., and Ohnishi K. Arsenic trioxide therapy in relapsed or refractory japanese patients with acute promyelocytic leukemia: updated outcomes of the phase II study and postremission therapies. Int. J. Hematol. 82 (2005) 224-229
45. Simeonova P.P., Hulderman T., Harki D., and Luster M.I. Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice. Environ. Health Perspect. 111 (2003) 1744-1748
46. Smith K.R., Klei L.R., and Barchowsky A. Arsenite stimulates plasma membrane NADPH oxidase in vascular endothelial cells. Am. J. Physiol. 280 (2001) L442-L449
47. Soucy N.V., Ihnat M.A., Kamat C.D., Hess L., Post M.J., Klei L.R., Clark C., and Barchowsky A. Arsenic stimulates angiogenesis and tumorigenesis in vivo. Toxicol. Sci. 76 (2003) 271-279
48. Soucy N.V., Klei L.R., Mayka D.D., and Barchowsky A. Signaling pathways for arsenic-stimulated vascular endothelial growth factor-a expression in primary vascular smooth muscle cells. Chem. Res. Toxicol. 17 (2004) 555-563
49. Soucy N.V., Mayka D., Klei L.R., Nemec A.A., Bauer J.A., and Barchowsky A. Neovascularization and angiogenic gene expression following chronic arsenic exposure in mice. Cardiovasc. Toxicol. 5 (2005) 29-42
50. Stolz D.B., Ross M.A., Salem H.M., Mars W.M., Michalopoulos G.K., and Enomoto K. Cationic colloidal silica membrane perturbation as a means of examining changes at the sinusoidal surface during liver regeneration. Am. J. Pathol. 155 (1999) 1487-1498
51. Straub A.C., Stolz D.B., Ross M.A., Hernández-Zavala A., Soucy N.V., Klei L.R., and Barchowsky A. Arsenic stimulates sinusoidal endothelial cell capillarization and vessel remodeling in mouse liver. Hepatology 45 (2007) 205-212
52. Tseng C.H., Chong C.K., Tseng C.P., Hsueh Y.M., Chiou H.Y., Tseng C.C., and Chen C.J. Long-term arsenic exposure and ischemic heart disease in arseniasis-hyperendemic villages in Taiwan. Toxicol. Lett. 137 (2003) 15-21
53. Tsuneyama K., Ohba K., Zen Y., Sato Y., Niwa H., Minato H., and Nakanuma Y. A comparative histological and morphometric study of vascular changes in idiopathic portal hypertension and alcoholic fibrosis/cirrhosis. Histopathology 43 (2003) 55-61
54. Wack K.E., Ross M.A., Zegarra V., Sysko L.R., Watkins S.C., and Stolz D.B. Sinusoidal ultrastructure evaluated during the revascularization of regenerating rat liver. Hepatology 33 (2001) 363-378
55. Ward N.L., Haninec A.L., Van Slyke P., Sled J.G., Sturk C., Henkelman R.M., Wanless I.R., and Dumont D.J. Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease. Am. J. Pathol. 165 (2004) 889-899
56. Wu M.M., Chiou H.Y., Hsueh Y.M., Hong C.T., Su C.L., Chang S.F., Huang W.L., Wang H.T., Wang Y.H., Hsieh Y.C., and Chen C.J. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis. Toxicol. Appl. Pharmacol. (2006) (Electronic publication)
57. Xu B., Broome U., Uzunel M., Nava S., Ge X., Kumagai-Braesch M., Hultenby K., Christensson B., Ericzon B.G., Holgersson J., and Sumitran-Holgersson S. Capillarization of hepatic sinusoid by liver endothelial cell-reactive autoantibodies in patients with cirrhosis and chronic hepatitis. Am. J. Pathol. 163 (2003) 1275-1289